References
- Tuberculosis Research Centre: Shortening short course chemotherapy. A randomized clinical trial for treatment of smear positive pulmonary tuberculosis with regimens using ofloxacin in the intensive phase. Ind J Tuberc 2002; 49: 27–38.
- Yew WW, Chau CK, Tam CM, Leung CC, Wong PC, Lee J. Outcomes of patients with multidrug-resistant pul-monary tuberculosis treated with ofloxacin/levofloxacin con-taining regimens. Chest 2000; 117: 744–751.
- Prasanta RM. Fluoroquinolones in multidrug-resistant tuberculosis. Am J Respir Crit Care Med 2004; 170 (8): 920.
- Takiff HE, Salazar L, Guerrero C et al. Cloning and nucleotide sequence of Mycobacterium tuberculosis gyr A and gyr B genes and detection of quinolone resistance muta-tions. Antimicrob Agents Chemother 1994; 38: 773–880.
- Hooper D, Wolfson JS. Mechanisms of bacterial resis-tance to quinolones. In Hooper D, Wolfson J eds: Quinolones, Antimicrobial agents. Washington, DC. American Society for Microbiology 1993; 97-118.
- Mitchison DA, Wallace JG, Bhatia AL, SeIkon JB, Lancaster MC. A comparison of the virulence in guinea pigs of South Indian and British tubercle bacilli. Tubercle 1960; 41: 1–22.
- Middlebrook G, Cohn ML. Some observations on the pathogenicity of isoniazid-resistant variants of tubercle bacilli. Science 1953; 118: 297–299.
- Joseph S, Mitchison DA, Ramachandran K, SeIkon JB Subbaiah TV. Virulence in the guinea -pig and sensitivity to PAS and thiacetazone of tubercle bacilli from south Indian patients with pulmonary tuberculosis. Tubercle 1964; 45 (4) 354–359.
- Grange JM, Aber VR, Allen BW, Mitchison DA, Goren MB. The correlation of bacteriophage types of Mycobacterium tuberculosis with guinea pig virulence and in vitro indicators of virulence. J Gen Microbiol. 1978; 108 (1): 1–7
- Bhatia AL. Characteristics of Indian tubercle bacilli. Ind J Chest Dis 1961; 3: 147–153.
- Sujatha N, Sulochana D, Renu G et al. Molecular epi-demiology of tuberculosis in a rural area of high prevalence in south India; Implications for disease control and prevention. J Clin Microbiol 2002; 40: 4785–4788
- Cheruvu M, Selvakumar N, Narayanan S, Narayanan PR. Mutations in the rpo B gene of multidrug-resistant Mycobacterium tuberculosis clinical isolates from India. J Clin Microbiol 2001; 39: 2987–2990.
- NCCLS. Susceptibility testing of Mycobacteria, Nocardia and Other Aerobic Actinomycetes. NCCLS docu-ment. 2003; M24-A 23: No.18, 1-71
- Sulochana S, Venkataraman P, Paramasivan CN. Evaluation of various methods of susceptibility to ofloxacin in strains of Mycobacterium tuberculosis. Ind J Med Res 1999; 110: 186–189.
- Sulochana S, Fathima Rahman, Paramasivan CN. In vitro activity of fluoroquinolones against Mycobacterium tuberculosis. J Chemother 2005; 17 (2): 169–173.
- World Health Organization. Anti tuberculosis drug resis-tance in the world. WHO/TB/97.229
- Hermans, Schuitema PWM, Van Soolingen ARJ et al Specific detection of Mycobacterium tuberculosis complex strains by polymerase chain reaction. J Clin Microbiol 1990; 28: Issue 6 pg 1204-1213.
- Siddiqi N, Shamim MN, Jain NK et al. Molecular Genetic analysis of multi drug resistance in Indian isolates of Mycobacterium tuberculosis. Mem inst Oswaldo Cruz, Rio de Janeiro, 1998; 93: 589–594
- Augustine FBC, Wing WY, Edward WCC, Miu LC, Mamie MMH, Raphael CYC. Multiplex PCR amplimer confor-mation analysis for rapid detection of gyr A mutations in fluo-roquinolone resistant Mycobacterium tuberculosis clinical iso-lates. Antimicrob Agents Chemother 2004; 48: 596–601.
- Kocagoz T, Hackbarth CJ, Unsal I, Rosenberg EY, Nikaido H, Chambers HF. Gyrase mutations in laboratory selected, fluoroquinolone resistant mutants of Mycobacterium tuberculosis H37Ra. Antimicrob Agents chemother 1996; 40: 1768–1774.
- Siddiqi N, Shamim MN, Hussain S et al. Molecular characterization of multidrug resistant isolates of Mycobacterium tuberuculosis from patients in North India.Antimicrob Agents Chemother 2002; 46: 443–450.
- Giannoni F, Iona E, Sementilli F et al. Evaluation of a new line probe assay for rapid identification of gyr A muta-tions in Mycobacterium tuberculosis. Antimicrob Agents Chemother 2005; 49: 2928–2933.
- Aubry A, Veziris N, Cambau E, Pernot CT, Jarlier V, Fisher LM. Novel gyrase mutations in quinolones - resistant and hypersusceptible clinical isolates of Mycobacterium tuber-culosis: Functional analysis of mutant enzymes. Antimicrob Agents Chemother 2006; 50: 104–112.